Glen Eagle Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Buy |
4,336
+15
| +0.3% | +$940 | 0.04% | 219 |
|
|
2025
Q1 | $260K | Sell |
4,321
-1,092
| -20% | -$65.7K | 0.04% | 224 |
|
|
2024
Q4 | $316K | Sell |
5,413
-484
| -8% | -$28.2K | 0.05% | 194 |
|
|
2024
Q3 | $349K | Sell |
5,897
-1,589
| -21% | -$94.1K | 0.06% | 181 |
|
|
2024
Q2 | $420K | Sell |
7,486
-449
| -6% | -$25.2K | 0.08% | 151 |
|
|
2024
Q1 | $465K | Buy |
7,935
+100
| +1% | +$5.86K | 0.09% | 149 |
|
|
2023
Q4 | $423K | Buy |
7,835
+1
| +0% | +$54 | 0.09% | 154 |
|
|
2023
Q3 | $380K | Hold |
7,834
| – | – | 0.09% | 152 |
|
|
2023
Q2 | $442K | Sell |
7,834
-239
| -3% | -$13.5K | 0.1% | 151 |
|
|
2023
Q1 | $436K | Hold |
8,073
| – | – | 0.11% | 140 |
|
|
2022
Q4 | $424K | Hold |
8,073
| – | – | 0.12% | 141 |
|
|
2022
Q3 | $381K | Buy |
8,073
+1
| +0% | +$47 | 0.11% | 147 |
|
|
2022
Q2 | $407K | Sell |
8,072
-137
| -2% | -$6.91K | 0.11% | 152 |
|
|
2022
Q1 | $500K | Hold |
8,209
| – | – | 0.13% | 142 |
|
|
2021
Q4 | $541K | Hold |
8,209
| – | – | 0.14% | 140 |
|
|
2021
Q3 | $515K | Buy |
8,209
+1
| +0% | +$63 | 0.15% | 136 |
|
|
2021
Q2 | $494K | Hold |
8,208
| – | – | 0.15% | 130 |
|
|
2021
Q1 | $452K | Buy |
8,208
+660
| +9% | +$36.3K | 0.16% | 118 |
|
|
2020
Q4 | $412K | Buy |
7,548
+2,850
| +61% | +$155K | 0.16% | 116 |
|
|
2020
Q3 | $235K | Buy |
4,698
+870
| +23% | +$43.4K | 0.11% | 145 |
|
|
2020
Q2 | $169K | Buy |
3,828
+3,228
| +538% | +$142K | 0.09% | 164 |
|
|
2020
Q1 | $22.5K | Hold |
600
| – | – | 0.02% | 388 |
|
|
2019
Q4 | $26.4K | Buy |
+600
| New | +$26.4K | 0.01% | 420 |
|